A Case of Primary Refractory Immune Thrombocytopenia: Challenges in Choice of Therapies
Joint Authors
Source
Issue
Vol. 2018, Issue 2018 (31 Dec. 2018), pp.1-4, 4 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2018-07-03
Country of Publication
Egypt
No. of Pages
4
Main Subjects
Abstract EN
The value of combination therapy for refractory ITP is not well defined.
We present the case of a 29-year-old male with severe ITP refractory to initial standard therapy including steroids, IVIG, and subsequent splenectomy, who was treated with the combination therapy of rituximab, romiplostim, and mycophenolate and eventually developed thrombocytosis requiring plateletpheresis.
Our case highlights the importance of the need to understand predictors of response to standard upfront treatment of acute ITP.
American Psychological Association (APA)
Wang, Hanyin& Tuncer, Hande. 2018. A Case of Primary Refractory Immune Thrombocytopenia: Challenges in Choice of Therapies. Case Reports in Hematology،Vol. 2018, no. 2018, pp.1-4.
https://search.emarefa.net/detail/BIM-1144057
Modern Language Association (MLA)
Wang, Hanyin& Tuncer, Hande. A Case of Primary Refractory Immune Thrombocytopenia: Challenges in Choice of Therapies. Case Reports in Hematology No. 2018 (2018), pp.1-4.
https://search.emarefa.net/detail/BIM-1144057
American Medical Association (AMA)
Wang, Hanyin& Tuncer, Hande. A Case of Primary Refractory Immune Thrombocytopenia: Challenges in Choice of Therapies. Case Reports in Hematology. 2018. Vol. 2018, no. 2018, pp.1-4.
https://search.emarefa.net/detail/BIM-1144057
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1144057
